Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma

NCT02410733

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Johann Wolfgang Goethe Universität Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie Frankfurt, Germany
  • Universität Heidelberg, Dermatologie und NCT Heidelberg, Germany
  • Universitätsmedizin Mainz, Hautklinik und Poliklinik Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Dermatologie, Venerologie und Allergologie Mannheim, Germany
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

NCT05199584

Conditions
Adenoma, Adenoma, Islet Cell, Brain Diseases, +52 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Zion, Illinois, United States
View all 16 locations
View Trial Details
Completed

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

NCT01909453

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • Retinal Consultants of Alabama P.C. Birmingham, Alabama, United States
  • UAB Callahan Eye Hospital Birmingham, Alabama, United States
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • UAB The Kirklin Clinic Birmingham, Alabama, United States
View all 282 locations
View Trial Details

Related conditions